We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
The Zacks Analyst Blog Highlights AbbVie PepsiCo, The Walt Disney, Caterpillar and PBF Energy
Read MoreHide Full Article
For Immediate Release
Chicago, IL – November 23, 2022 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: AbbVie Inc. (ABBV - Free Report) , PepsiCo, Inc. (PEP - Free Report) , The Walt Disney Co. (DIS - Free Report) , Caterpillar Inc. (CAT - Free Report) and PBF Energy Inc. (PBF - Free Report) .
Here are highlights from Tuesday’s Analyst Blog:
Top Stock Reports for AbbVie, PepsiCo and Walt Disney
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including AbbVie Inc., PepsiCo, Inc. and The Walt Disney Co. These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.
AbbVie's shares have handily outperformed the Zacks Large Cap Pharmaceuticals industry over the past year (+35.9% vs. +13.4%) on the back of favorable outlook for its cancer drugs and pipeline of drugs. The company has successfully expanded the labels of its cancer drugs, Imbruvica and Venclexta. It has several new drugs in its portfolio, which have the potential to drive revenues once Humira loses U.S. exclusivity in 2023.
Skyrizi and Rinvoq have established outstanding launch trajectories bolstered by the approval of new indications. It has several early/mid-stage candidates that have blockbuster potential.
However, there are concerns about long-term sales growth once Humira generics enter the U.S. market. Increasing competition from newer therapies is hurting Imbruvica's sales. Slowing consumer demand due to economic pressures is affecting sales of the aesthetics franchise.
Shares of PepsiCo have modestly outperformed the Zacks Beverages - Soft drinks industry over the past year (+12.6% vs. +11.1%). The company's revenues and earnings beat the Zacks Consensus Estimate and improved year over year in the third quarter. This marked the 17th straight quarter of sales beat.
PepsiCo benefits from the resilience and strength of global beverage and convenient food businesses. It expects to benefit by delivering convenience, variety and value proposition to customers through its brands. It raised its revenue view for 2022.
However, PepsiCo witnessed margin pressures in the third quarter driven by impacts of supply-chain disruptions and inflationary labor, transportation and commodity costs. PEP anticipates incremental input cost inflation for the balance of 2022. Adverse currency rates also remain headwinds.
Walt Disney shares have reacted favorably to the leadership change announcement, but the stock has otherwise been laggard (down -38.6% vs. -18.3% for the S&P 500 index). The company's profitability was negatively impacted by higher programming and production costs across Disney+, ESPN+ and Hulu. Disney's leveraged balance sheet remains a concern.
However, the company's fourth-quarter fiscal 2022 results reflected strength in Disney+ and revival in Parks, Experiences and Products businesses. The company benefits from the growing popularity of Disney+, owing to a strong content portfolio and a cheaper bundle offering.
Availability in the Nordics, Latin America and other Asian territories is helping it expand its user base. Theme Park business is likely to gain from strong demand across both the domestic and international parks. Per capita spending increased 6% year over year, while occupancy at domestic hotels was 90% in the fiscal fourth quarter.
Other noteworthy reports we are featuring today include Caterpillar Inc. and PBF Energy Inc..
Why Haven't You Looked at Zacks' Top Stocks?
Our 5 best-performing strategies have blown away the S&P's impressive +28.8% gain in 2021. Amazingly, they soared +40.3%, +48.2%, +67.6%, +94.4%, and +95.3%. Today you can access their live picks without cost or obligation.
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Shutterstock
The Zacks Analyst Blog Highlights AbbVie PepsiCo, The Walt Disney, Caterpillar and PBF Energy
For Immediate Release
Chicago, IL – November 23, 2022 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: AbbVie Inc. (ABBV - Free Report) , PepsiCo, Inc. (PEP - Free Report) , The Walt Disney Co. (DIS - Free Report) , Caterpillar Inc. (CAT - Free Report) and PBF Energy Inc. (PBF - Free Report) .
Here are highlights from Tuesday’s Analyst Blog:
Top Stock Reports for AbbVie, PepsiCo and Walt Disney
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including AbbVie Inc., PepsiCo, Inc. and The Walt Disney Co. These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.
You can see all of today's research reports here >>>
AbbVie's shares have handily outperformed the Zacks Large Cap Pharmaceuticals industry over the past year (+35.9% vs. +13.4%) on the back of favorable outlook for its cancer drugs and pipeline of drugs. The company has successfully expanded the labels of its cancer drugs, Imbruvica and Venclexta. It has several new drugs in its portfolio, which have the potential to drive revenues once Humira loses U.S. exclusivity in 2023.
Skyrizi and Rinvoq have established outstanding launch trajectories bolstered by the approval of new indications. It has several early/mid-stage candidates that have blockbuster potential.
However, there are concerns about long-term sales growth once Humira generics enter the U.S. market. Increasing competition from newer therapies is hurting Imbruvica's sales. Slowing consumer demand due to economic pressures is affecting sales of the aesthetics franchise.
(You can read the full research report on AbbVie here >>>)
Shares of PepsiCo have modestly outperformed the Zacks Beverages - Soft drinks industry over the past year (+12.6% vs. +11.1%). The company's revenues and earnings beat the Zacks Consensus Estimate and improved year over year in the third quarter. This marked the 17th straight quarter of sales beat.
PepsiCo benefits from the resilience and strength of global beverage and convenient food businesses. It expects to benefit by delivering convenience, variety and value proposition to customers through its brands. It raised its revenue view for 2022.
However, PepsiCo witnessed margin pressures in the third quarter driven by impacts of supply-chain disruptions and inflationary labor, transportation and commodity costs. PEP anticipates incremental input cost inflation for the balance of 2022. Adverse currency rates also remain headwinds.
(You can read the full research report on PepsiCo here >>>)
Walt Disney shares have reacted favorably to the leadership change announcement, but the stock has otherwise been laggard (down -38.6% vs. -18.3% for the S&P 500 index). The company's profitability was negatively impacted by higher programming and production costs across Disney+, ESPN+ and Hulu. Disney's leveraged balance sheet remains a concern.
However, the company's fourth-quarter fiscal 2022 results reflected strength in Disney+ and revival in Parks, Experiences and Products businesses. The company benefits from the growing popularity of Disney+, owing to a strong content portfolio and a cheaper bundle offering.
Availability in the Nordics, Latin America and other Asian territories is helping it expand its user base. Theme Park business is likely to gain from strong demand across both the domestic and international parks. Per capita spending increased 6% year over year, while occupancy at domestic hotels was 90% in the fiscal fourth quarter.
(You can read the full research report on The Walt Disney here >>>)
Other noteworthy reports we are featuring today include Caterpillar Inc. and PBF Energy Inc..
Why Haven't You Looked at Zacks' Top Stocks?
Our 5 best-performing strategies have blown away the S&P's impressive +28.8% gain in 2021. Amazingly, they soared +40.3%, +48.2%, +67.6%, +94.4%, and +95.3%. Today you can access their live picks without cost or obligation.
See Stocks Free >>
Media Contact
Zacks Investment Research
800-767-3771 ext. 9339
support@zacks.com
https://www.zacks.com
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.